Clinical Trial

Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy

Study acronym: PHYSPAVB
Recruiting
View on ClinicalTrials.gov →
Summary
The implantation of a pacemaker and conventional cardiac pacing from the right ventricle (apex or septum) is an effective and safe therapy for the treatment of patients with atrioventricular block and bradycardia.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-01-17; most recent amendment 2026-03-30.
Status change: Not Yet Recruiting → Recruiting 2022-03-16
Trial Details
NCT Number NCT05214365
Lead Sponsor Hospital Clinic of Barcelona
Collaborators: Institut d'Investigacions Biomèdiques August Pi i Sunyer, Consorcio Centro de Investigación Biomédica en Red (CIBER)
Conditions Conduction System Pacing, Conventional Ventricular Pacing
Enrollment 200 participants
Start Date 2022-02-01
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-31